Jim Cramer’s Latest Lightning Round: 7 Stocks in Focus

5. STERIS plc (NYSE:STE)

Number of Hedge Fund Holders: 48

A caller highlighted that STERIS plc (NYSE:STE) is at the rule of 40 and noting its 30% overseas revenue, mentioned that its growth is slowing down. Cramer replied:

“Geez, I always liked Steris. I think that that’s just a great kind of just a regular everyday healthcare company that I think should do very well. I did not know about the slowing. I think it’s just a strong company and I’d be a buyer of it.”

STERIS (NYSE:STE) provides infection prevention products and services, including sterilization equipment, maintenance, and support for healthcare, medical device, and pharmaceutical industries, as well as consumables for life sciences. The London Company stated the following regarding STERIS plc (NYSE:STE) in its Q4 2024 investor letter:

“STERIS plc (NYSE:STE) – STE underperformed in 4Q reflecting cautious health care sentiment, modestly lower growth for medical device sterilization, and the re-emergence of litigation concerns. After a noisy few years, we believe STE is getting back onto a steady trajectory of mid-to-high single digit revenue growth and low double-digit earnings growth. Our view of STE’s competitive positioning in the medical sterilization business is unchanged, and we do not expect litigation to have a material impact on the value of the company.”